Read + Share
Gordon MJ, Sureda A, Westin JR. Novel strategies for relapsed/refractory DLBCL; navigating the immunotherapy era
in aggressive lymphoma. Leuk Lymphoma 2022 May 12:1-11. doi: 10.1080/10428194.2022.2068007.
PMID: 35549635
|
 |
|
Gordon MJ, Sureda A, Westin JR. Novel strategies for relapsed/refractory DLBCL; navigating the immunotherapy era
in aggressive lymphoma. Leuk Lymphoma 2022 May 12:1-11. doi: 10.1080/10428194.2022.2068007.
PMID: 35549635
|
|
|
|